Phase 4 COPD and Suboptimal Inspiratory Flow Rate

Clinical trial NCT05165485 · COMPLETED

Trial details

NCT number: NCT05165485
Sponsor: Theravance Biopharma
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2022-01-07
Primary completion: 2023-11-13
Enrollment: 404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.